Evidence map›Paper›PMID 32058469›Full record

ArticleMedicine and science in sports and exercise2020

Cachexia Disrupts Diurnal Regulation of Activity, Feeding, and Muscle Mechanistic Target of Rapamycin Complex 1 in Mice.

Brittany R Counts, Justin P Hardee, Dennis K Fix, Brandon N Vanderveen, Ryan N Montalvo, James A Carson

Open access · greenAbstract read
In one paragraph

Article in Medicine and science in sports and exercise, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Cancer Cachexia.Advances in experimental medicine and biology · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Recovery from FOLFOX chemotherapy-induced systemic and skeletal muscle metabolic dysfunction in mice.American journal of physiology. Endocrinology and metabolism · 2023
    Article
  8. Review
  9. Article
  10. Muscular contraction's therapeutic potential for cancer-induced wasting.American journal of physiology. Cell physiology · 2022
    Review
  11. Article
  12. Article
  13. Exercise as a therapy for cancer-induced muscle wasting.Sports medicine and health science · 2020
    Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Brittany R CountsIntegrative Muscle Biology Laboratory, Division of Rehabilitation Sciences, College of Health Professions, University of Tennessee Health Science Center, Memphis TN.
Justin P HardeeIntegrative Muscle Biology Laboratory, Department of Exercise Science, University of South Carolina, Columbia, SC.
Dennis K FixIntegrative Muscle Biology Laboratory, Department of Exercise Science, University of South Carolina, Columbia, SC.
Brandon N VanderveenIntegrative Muscle Biology Laboratory, Department of Exercise Science, University of South Carolina, Columbia, SC.
Ryan N MontalvoIntegrative Muscle Biology Laboratory, Department of Exercise Science, University of South Carolina, Columbia, SC.
James A CarsonIntegrative Muscle Biology Laboratory, Division of Rehabilitation Sciences, College of Health Professions, University of Tennessee Health Science Center, Memphis TN.
University of South Carolina · USUniversity of Tennessee Health Science Center · US

Funding

Cachexia in ApcMin/+ mice: The role of IL-6R01CA121249 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI CARSON, JAMES A · 2008 to 2018
$2.7M
NCI NIH HHS R01 CA121249
6 · The paper itself

Abstract

introductionCancer cachexia is characterized by severe skeletal muscle mass loss, which is driven by decreased muscle protein synthesis and increased protein degradation. Daily physical activity and feeding behaviors exhibit diurnal fluctuations in mice that can impact the systemic environment and skeletal muscle signaling. PURPOSE: We investigated the effect of cancer cachexia on the diurnal regulation of feeding, physical activity, and skeletal muscle mechanistic target of rapamycin complex 1 (mTORC1) signaling in tumor-bearing mice. We also examined the impact of increased physical activity on diurnal behaviors and skeletal muscle mTROC1 signaling in the cancer environment.

methodsPhysical activity and feeding behaviors were measured for four consecutive days before sacrifice in male C57BL/6 (B6; n = 24) and Apc (MIN; n = 22) mice at 7:00 AM and 7:00 PM under ad libitum condition. A subset of B6 (n = 16) and MIN (n = 19) mice were given wheel access for 2 wk before diurnal behavior measurements. Gastrocnemius muscle protein expression was examined.

resultsThe MIN mice demonstrated altered diurnal fluctuations in feeding and activity compared with the B6. Interestingly, cachexia did not alter MIN total food intake, but dramatically reduced cage physical activity. As a measurement of mTORC1 activity, 4E-BP1 phosphorylation increased after the dark cycle in B6 and precachectic MIN mice, whereas rpS6 phosphorylation was only increased after the dark cycle in MIN mice. MIN 4E-BP1 phosphorylation at the end of the light cycle was significantly correlated with cachexia progression and reduced physical activity. Voluntary wheel running increased light cycle MIN 4E-BP1 phosphorylation and attenuated muscle mass loss.

conclusionsThe cancer environment can alter diurnal feeding and physical activity behaviors in tumor-bearing mice, which are linked to the progression of cachexia and muscle wasting. Furthermore, suppressed physical activity during cachexia is associated with decreased skeletal muscle mTORC1 signaling.

Indexed as

AnimalsBlood GlucoseCachexiaCircadian RhythmFeeding BehaviorLiverMaleMechanistic Target of Rapamycin Complex 1Mice, Inbred C57BLMotor ActivityMuscle, SkeletalOrgan SizePhysical Conditioning, AnimalSignal TransductionStomachBlood GlucoseMechanistic Target of Rapamycin Complex 1

Identifiers

PMID32058469
PMCPMC7182083
OpenAlexW2981883066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.